Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of

A novel ELISA for the detection of active form of plasminogen activator inhibitor-1 based on a highly specific trapping agent - ScienceDirect

Increased expression of plasminogen activator inhibitor-1 (PAI-1) is associated with depression and depressive phenotype in C57Bl/6J mice

Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis, Thrombosis Journal

Plasminogen activator inhibitor 1 (PAI-1) E. coli, = 90 SDS-PAGE 140208-23-7

Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson's disease - ScienceDirect

Frontiers Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells

Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase

Plasminogen Activator Inhibitor 1: Physiological and Pathophysiological Roles

Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome

TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription

Biomolecules, Free Full-Text

Inhibition of PAI (Plasminogen Activator Inhibitor)-1 Improves Brain Collateral Perfusion and Injury After Acute Ischemic Stroke in Aged Hypertensive Rats

Elevation of Plasminogen Activator Inhibitor-1 Promotes Differentiation of Cancer Stem-Like Cell State by Hepatitis C Virus Infection

IJMS, Free Full-Text

Proposed roles of local and circulating plasminogen activator inhibitor